Eli Lilly In Hot Seat Again Over Zyprexa
Fresh off a $495 million product-liability settlement over Zyprexa, Eli Lilly & Co. is facing more scrutiny, with Illinois and Vermont requesting that the pharmaceutical giant hand over material detailing how...To view the full article, register now.
Already a subscriber? Click here to view full article